48 related articles for article (PubMed ID: 24575633)
1. [Toxoplasma gondii infection in pregnant women].
Jerant PV; Milosević V; Hrnjaković Cvjetković I; Patić A; Stefan Mikić S; Ristić M
Med Pregl; 2013; 66(11-12):459-63. PubMed ID: 24575633
[TBL] [Abstract][Full Text] [Related]
2. Seroprevalence and risk factors of Toxoplasma gondii infection in pregnant women following antenatal care at Mizan Aman General Hospital, Bench Maji Zone (BMZ), Ethiopia.
Abamecha F; Awel H
BMC Infect Dis; 2016 Sep; 16(1):460. PubMed ID: 27585863
[TBL] [Abstract][Full Text] [Related]
3. Anti-Toxoplasma gondii antibodies in pregnant women and their newborn infants in the region of São José do Rio Preto, São Paulo, Brazil.
Mattos Cde C; Spegiorin LC; Meira Cda S; Silva Tda C; Ferreira AI; Nakashima F; Pereira-Chioccola VL; Mattos LC
Sao Paulo Med J; 2011; 129(4):261-6. PubMed ID: 21971902
[TBL] [Abstract][Full Text] [Related]
4. Rubella virus,
Mirambo MM; Mshana SE; Groß U
Afr Health Sci; 2019 Jun; 19(2):1858-1865. PubMed ID: 31656468
[TBL] [Abstract][Full Text] [Related]
5. Seroprevalence of toxoplasmosis in pregnant women of the Marrakech-Safi region, Morocco.
Hoummadi L; Berrouch S; Amraouza Y; Adel A; Mriouch M; Soraa N; El Jahiri Y; Zoughari L; Benbouzid A; Miss EM; Moutaj R; Hafid J
Afr Health Sci; 2020 Mar; 20(1):59-63. PubMed ID: 33402893
[TBL] [Abstract][Full Text] [Related]
6. Seroepidemiology of toxoplasmosis in pregnant women and detection of infection acquired during pregnancy in Cotonou, Benin.
Amagbégnon R; Dechavanne C; Dambrun M; Yehouénou U; Akondé N; Migot-Nabias F; Nounnagnon Tonouhéwa AB; Hamidović A; Fievet N; Tonato-Bagnan A; Ogouyemi-Hounto A; Alao MJ; Dardé ML; Mercier A; Kindé-Gazard D
Parasite; 2023; 30():43. PubMed ID: 37855713
[TBL] [Abstract][Full Text] [Related]
7. Socio-demographic determinants of Toxoplasma gondii seroprevalence in migrant workers of Peninsular Malaysia.
Sahimin N; Lim YAL; Ariffin F; Behnke JM; Basáñez MG; Walker M; Lewis JW; Noordin R; Abdullah KA; Mohd Zain SN
Parasit Vectors; 2017 May; 10(1):238. PubMed ID: 28506241
[TBL] [Abstract][Full Text] [Related]
8. Seromolecular study on the prevalence and risk factors of Toxoplasma gondii infection in pregnant women referred to a gynecology hospital in Urmia, northwest part of Iran in 2022.
Bashour N; Aminpour A; Vazifehkhah S; Jafari R
BMC Infect Dis; 2024 Apr; 24(1):410. PubMed ID: 38632544
[TBL] [Abstract][Full Text] [Related]
9. Impact of chronic toxoplasmosis in pregnancy: association between maternal seropositivity for Toxoplasma gondii IgG antibodies and fetal growth restriction.
Martinez VO; Dos Santos NR; Bah HAF; Junior EAG; Costa DO; Menezes-Filho JA
Parasitol Res; 2023 Dec; 123(1):25. PubMed ID: 38072839
[TBL] [Abstract][Full Text] [Related]
10. Investigation of
Yıldırım A; Ataş AD
Turkiye Parazitol Derg; 2023 Dec; 47(4):209-213. PubMed ID: 38149440
[TBL] [Abstract][Full Text] [Related]
11. Toxoplasma gondii IgG avidity for the diagnosis of primary infection in pregnant women: Comparison between chemiluminescent microparticle immunoassay and enzyme-linked immunosorbent assay.
Ota H; Yamada H; Wada S; Tanimura K; Deguchi M; Uchida A; Nishikawa A
J Infect Chemother; 2024 May; 30(5):434-438. PubMed ID: 38000499
[TBL] [Abstract][Full Text] [Related]
12. Prospective evalution of pregnant women with suspected acute toxoplasmosis treated in a reference prenatal care clinic at a university teaching hospital in Southern Brazil.
Evangelista FF; Mantelo FM; Lima KK; Marchioro AA; Beletini LF; Souza AH; Santana PL; Riedo CO; Higa LT; Guilherme ALF
Rev Inst Med Trop Sao Paulo; 2020; 62():e46. PubMed ID: 32667393
[TBL] [Abstract][Full Text] [Related]
13. Toxoplasma gondii seroprevalence among pregnant women in Rabat, Morocco.
Laboudi M; Taghy Z; Duieb O; Peyron F; Sadak A
Trop Med Health; 2021 Mar; 49(1):21. PubMed ID: 33685529
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the prevalence of risk factors for Toxoplasma Gondii infection among pregnant women in rural and urban areas in Poland.
Bieńkowski C; Stępień M; Cholewik M; Aniszewska M; Pokorska-Śpiewak M
Przegl Epidemiol; 2023; 77(3):291-301. PubMed ID: 38329025
[TBL] [Abstract][Full Text] [Related]
15. Seroinfection of Antibodies to
Cubas-Alarcón D; Guevara-Vásquez GM; Suclupe-Campos DO; Castro-Martínez S; Aguilar-Gamboa FR; Failoc-Rojas VE
Infect Dis Obstet Gynecol; 2024; 2024():8844325. PubMed ID: 38883209
[TBL] [Abstract][Full Text] [Related]
16. Serosurvey of
Pereira ELGM; Ferreira IB; Victorino RB; Lescano SAZ; Giuffrida R; Kmetiuk LB; Biondo AW; Santarém VA
Front Public Health; 2024; 12():1340434. PubMed ID: 38333736
[TBL] [Abstract][Full Text] [Related]
17. Correlation of toxoplasmosis with small‑for‑gestational‑age newborns.
Hurt K; Kodym P; Stejskal D; Cihar M; Rakovic J; Zikan M
Bratisl Lek Listy; 2024; 125(2):92-95. PubMed ID: 38219061
[TBL] [Abstract][Full Text] [Related]
18. Adverse pregnancy outcomes in Toxoplasma gondii seropositive Hispanic women.
Mutka T; Seyfang A; Yoo JY; Dutra SVO; Ji M; Louis-Jacques A; Bruder K; Prescott S; Kim K; Groer M
J Obstet Gynaecol Res; 2023 Mar; 49(3):893-903. PubMed ID: 36495217
[TBL] [Abstract][Full Text] [Related]
19. Neuroserpin, IL-33 and IL-17A as potential markers of mild symptoms of depressive syndrome in
Silva ZM; Toledo DNM; Pio S; Machado BAA; Dos Santos PV; Hó FG; Medina YN; Cordeiro PHM; Perucci LO; Pinto KMC; Talvani A
Front Immunol; 2024; 15():1394456. PubMed ID: 38835777
[TBL] [Abstract][Full Text] [Related]
20.
Duffy AR; O'Connell JR; Pavlovich M; Ryan KA; Lowry CA; Daue M; Raheja UK; Brenner LA; Markon AO; Punzalan CM; Dagdag A; Hill DE; Pollin TI; Seyfang A; Groer MW; Mitchell BD; Postolache TT
Int J Environ Res Public Health; 2019 Oct; 16(19):. PubMed ID: 31623376
[No Abstract] [Full Text] [Related]
[Next] [New Search]
